Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001703057-26-000012
Filing Date
2026-02-24
Accepted
2026-02-24 16:38:24
Documents
107
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abcl-20251231.htm   iXBRL 10-K 2128364
2 EX-21.1 exhibit211.htm EX-21.1 1173
3 EX-23.1 abclfeb2026consent-10xk.htm EX-23.1 1910
4 EX-31.1 abcl-20251231xexx311.htm EX-31.1 10568
5 EX-31.2 abcl-20251231xexx312.htm EX-31.2 10533
6 EX-32.1 abcl-20251231xexx321.htm EX-32.1 5069
7 EX-32.2 abcl-20251231xexx322.htm EX-32.2 5046
13 abcl-20251231_g1.jpg GRAPHIC 373151
14 abcl-20251231_g2.jpg GRAPHIC 419038
15 abcl-20251231_g3.jpg GRAPHIC 449770
16 abcl-20251231_g4.jpg GRAPHIC 1252519
17 abcl-20251231_g5.jpg GRAPHIC 1305717
18 abcl-20251231_g6.jpg GRAPHIC 123886
19 abcl-20251231_g7.jpg GRAPHIC 212621
20 abcl-20251231_g8.jpg GRAPHIC 67396
21 abclfeb2026consent-10xk001.jpg GRAPHIC 103756
22 exhibit211001.jpg GRAPHIC 56565
  Complete submission text file 0001703057-26-000012.txt   19363816

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20251231.xsd EX-101.SCH 65858
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abcl-20251231_cal.xml EX-101.CAL 98078
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abcl-20251231_def.xml EX-101.DEF 298392
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20251231_lab.xml EX-101.LAB 801045
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20251231_pre.xml EX-101.PRE 558894
110 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20251231_htm.xml XML 1185545
Mailing Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39781 | Film No.: 26672345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)